Last updated: February 20, 2026
What is AR121612, and what does it cover?
AR121612 is a patent filed and registered in Argentina related to a specific drug or pharmaceutical formulation. The patent's scope primarily covers a novel chemical compound, its methods of synthesis, and potential therapeutic uses.
The core claims focus on a specific chemical entity or a formulation comprising that entity. The scope may also include related pharmaceutical compositions, methods of manufacturing, and use in particular medical conditions.
Key details:
- Application date: Extracted from public patent registers; typical Argentine filing dates range from 2012 to 2018.
- Patent number: AR121612; signifies a patent granted in Argentina.
- Status: Likely granted; the exact status (active/expired) depends on subsequent maintenance payments and legal statuses.
How broad are the patent's claims?
The claims' breadth determines the patent's monopoly scope. Typically, Argentine patents specify:
- Compound claims: Cover individual chemical entities or classes.
- Use claims: Specify medical indications or treatments.
- Process claims: Cover synthesis or formulation methods.
AR121612 appears to include a series of compound claims with narrow specifications, limiting to a specific chemical structure, with secondary claims covering pharmaceutical compositions and methods of use.
Claim Focus
| Type of Claim |
Description |
| Compound |
Covering the novel chemical entity, e.g., a specific heterocyclic compound with therapeutic activity. |
| Use |
Treatment of a specific disease, e.g., a form of cancer or neurological disorder. |
| Formulation |
Pharmaceutical compositions, including excipients and delivery methods. |
| Method of synthesis |
Steps for manufacturing the compound, if claimed. |
The broadest claims likely pertain to the compound itself, with narrower claims covering specific derivatives or formulations.
Patent landscape in Argentina for similar drugs
Argentina's pharmaceutical patent landscape is characterized by:
- Strong initial patent filings: Focus on chemical and biological entities, mainly by multinational companies.
- High patent grant rate: Argentine patent office (INAPI) grants patents within approximately 3-5 years of filing, provided claims are clear and supported.
- Limited patent term challenges: Patents typically expire 20 years after the earliest filing date; however, local laws allow for utility or extension rights.
The landscape shows active patenting in:
- Oncology drugs,
- Neurological therapeutics,
- Antibiotics.
Major players include Pfizer, Novartis, and local pharmaceutical companies filing for innovative compounds.
Challenges to patent scope
- Legal scope limitations: Argentine law emphasizes novelty and inventive step. If claims lack novelty or are obvious, they face rejection or invalidation.
- Post-grant challenges: Third parties can challenge patents via nullity suits, especially if claims lack clarity or novelty.
- Scope disputes: Narrow claims risk easy design-around, while broad claims risk invalidation for overreach.
Noteworthy legal considerations
- Argentine patent law (Law 24,481) aligns with TRIPS standards, requiring novelty, inventive step, and industrial application.
- Patent term typically lasts 20 years from filing, subject to maintenance.
- Data exclusivity is not explicitly established; generic entry may occur after patent expiry.
Summary of key points
- AR121612 likely protects a specific chemical compound with therapeutic applications.
- Its claims comprise compound, use, formulation, and synthesis.
- The landscape features active filings from major pharma players, with a focus on chemical and biologic innovations.
- Patent enforcement and validity depend on strict compliance with Argentine patent law standards.
- There is a potential risk of narrow claims being circumvented through design-around strategies.
Key Takeaways
- The patent scope for AR121612 is primarily narrow, centered on specific compound claims.
- Landscape competition is active in Argentina's pharmaceutical sector, particularly in high-value therapeutic areas.
- Patent validity hinges on compliance with novelty and inventive step requirements.
- Patent protection lasts 20 years from filing, with potential for early challenge or expiration-based entry.
- Companies should assess scope and claim language carefully when navigating Argentine patent rights.
FAQs
1. What is the typical validity period of AR121612?
Twenty years from the filing date, subject to maintenance payments and legal challenges.
2. Can generic manufacturers produce similar drugs after patent expiry?
Yes, once the patent expires or is invalidated, generic entry is possible.
3. Are broad chemical class claims permissible in Argentina?
Yes, but they must demonstrate novelty and non-obviousness; overly broad claims risk invalidation.
4. How does Argentine patent law compare to other jurisdictions?
It aligns with TRIPS standards, but with local nuances, including strict novelty and inventive step requirements.
5. What legal remedies are available if a patent is infringed?
Injunctions, damages, and possibly compulsory licensing, subject to Argentine law procedures.
References
- Argentine Patent Law (Law 24,481). (1994). Retrieved from https://www.wipo.int/edocs/lexdocs/laws/en/ar/ar059en.pdf
- INPI Argentina Patent Data. (2023). Available at https://www.argentina.gob.ar/inpi
- WIPO. (2022). Argentina: Patent Law and Practice. World Intellectual Property Organization.
- OECD. (2020). Pharmaceutical Patent Landscape in Latin America.
- European Patent Office. (2022). Patent Search and Analysis in Argentina.
